<?xml version="1.0" encoding="UTF-8"?>
<document id="29667444">
	<sentence id="s1" text="PM were loaded with a siRNA against positive regulation of cell migration, an important oncogene involved in breast cancer tumorigenesis, with a special role in CSC malignancy.">
		<entity id="s1.e1" charOffset="36-73"
			type="GO" text="positive regulation of cell migration" ontology_id="GO_0030335"/>
		<entity id="s1.e2" charOffset="116-122"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s1.e3" charOffset="123-128"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Efficacy of sipositive regulation of cell migration-PM was validated in CSC isolated from two breast cancer cell lines: MCF-7 and Triple Negative MDA-MB-231 corresponding to an aggressive subtype of breast cancer.">
		<entity id="s2.e1" charOffset="14-51"
			type="GO" text="positive regulation of cell migration" ontology_id="GO_0030335"/>
		<entity id="s2.e2" charOffset="101-107"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="These results prompt positive regulation of cell migration inhibition as a powerful therapeutic target against CSC and pave the way to the appearance of more effective nanomedicine-based gene therapies aimed to prevent CSC-related tumor recurrence">
		<entity id="s3.e1" charOffset="21-58"
			type="GO" text="positive regulation of cell migration" ontology_id="GO_0030335"/>
		<entity id="s3.e2" charOffset="231-236"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
</document>
